Bli medlem
Bli medlem

Du är här

2016-11-11

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 10 November 2016

Bagsværd, Denmark, 11 November 2016
- This document discloses the data of the transaction(s) made in Novo Nordisk
shares by the company's board members, executives and their associated
persons in accordance with Article 19 of Regulation No. 596/2014 on market
abuse.

The company's board members, executives and their associated persons have
given Novo Nordisk power of attorney on their behalf to publish trading in
Novo Nordisk shares by the company's board members, executives and their
associated persons.

Further information

-----------------------------------------------------------------
| Media: |
| Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com |
| Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com |
| |
| Investors: |
| Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com |
| Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com |
| Hanna Ögren +45 3079 8519 haoe@novonordisk.com |
| Anders Mikkelsen +45 3079 4461 armk@novonordisk.com |
| Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com |
-----------------------------------------------------------------
Company announcement No 79 / 2016

CA161111_Trading_UK
http://hugin.info/2013/R/2056439/770233.pdf

---------------------------------------
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.